Jerome A Moore

Title: Jerome A. Moore: Innovator in High Dose IGF-1 Therapy

Introduction

Jerome A. Moore is a notable inventor based in San Mateo, California. He has made significant contributions to the field of medical therapies, particularly through his innovative work on high dose IGF-1 therapy. His research and inventions have the potential to impact the treatment of various health conditions.

Latest Patents

Jerome A. Moore holds a patent for a method of providing high dose IGF-I therapy. This invention involves administering a complex of IGF-I and IGFBP-3. The unique aspect of this therapy is that the IGF-I/IGFBP-3 complex can be given at unexpectedly high doses without inducing IGF-I-related side effects. This advancement could lead to more effective treatment options for patients.

Career Highlights

Jerome A. Moore is associated with Celtrix Pharmaceuticals, Inc., where he continues to develop and refine his innovative therapies. His work at the company has positioned him as a key player in the pharmaceutical industry, particularly in the realm of growth factor therapies.

Collaborations

Throughout his career, Jerome has collaborated with notable colleagues, including Andreas Sommer and Steven W. Adams. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Jerome A. Moore's contributions to high dose IGF-1 therapy exemplify the impact of innovative thinking in the medical field. His work not only advances therapeutic options but also highlights the importance of collaboration in driving scientific progress.